Therapeutic angiogenesis for cardiovascular disease

AUTOR(ES)

Ng, Yin-Shan

FONTE

BioMed Central

RESUMO

The identification of angiogenic growth factors, such as vascular endothelial growth factor and fibroblast growth factor, has fueled interest in using such factors to induce therapeutic angiogenesis. The results of numerous animal studies and clinical trials have offered promise for new treatment strategies for various ischemic diseases. Increased understanding of the cellular and molecular biology of vessel growth has, however, prompted investigators and clinicians alike to reconsider the complexity of therapeutic angiogenesis. The realization that formation of a stable vessel is a complex, multistep process may provide useful insights into the design of the next generation of angiogenesis therapy.

Documentos Relacionados

• A Renewed Emphasis on Therapeutic Angiogenesis Research for CAD
• Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization
• Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention
• The diversity of endothelial cells: a challenge for therapeutic angiogenesis
• Therapeutic Angiogenesis: The Present and the Future